Cholinergic mediation of the inhibitory effect of methylphenidate on neuronal activity in the reticular formation.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008774:Methylphenidate / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects*; D009538:Nicotine / Q000494:pharmacology; D010095:Oxotremorine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D051381:Rats; D012154:Reticular Formation / Q000166:cytology*; D013997:Time Factors
D006584:Hexamethonium Compounds; D008774:Methylphenidate; D010095:Oxotremorine; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine